Peden K - Search Results

1

Biological activity of residual cell-substrate DNA.

Peden K, Sheng L, Pal A, Lewis A. Peden K, et al. Dev Biol (Basel). 2006;123:45-53; discussion 55-73. Dev Biol (Basel). 2006. PMID: 16566436

2

Oncogenicity of DNA in vivo: tumor induction with expression plasmids for activated H-ras and c-myc.

Sheng L, Cai F, Zhu Y, Pal A, Athanasiou M, Orrison B, Blair DG, Hughes SH, Coffin JM, Lewis AM, Peden K. Sheng L, et al. Among authors: peden k. Biologicals. 2008 May;36(3):184-97. doi: 10.1016/j.biologicals.2007.11.003. Epub 2008 Jan 22. Biologicals. 2008. PMID: 18218323

3

Issues associated with residual cell-substrate DNA in viral vaccines.

Sheng-Fowler L, Lewis AM Jr, Peden K. Sheng-Fowler L, et al. Among authors: peden k. Biologicals. 2009 Jun;37(3):190-5. doi: 10.1016/j.biologicals.2009.02.015. Epub 2009 Mar 14. Biologicals. 2009. PMID: 19285882

4

Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivation.

Sheng-Fowler L, Lewis AM Jr, Peden K. Sheng-Fowler L, et al. Among authors: peden k. Biologicals. 2009 Aug;37(4):259-69. doi: 10.1016/j.biologicals.2009.04.002. Epub 2009 May 19. Biologicals. 2009. PMID: 19457682

5

Real-time, quantitative PCR assays for the detection of virus-specific DNA in samples with mixed populations of polyomaviruses.

Pal A, Sirota L, Maudru T, Peden K, Lewis AM Jr. Pal A, et al. Among authors: peden k. J Virol Methods. 2006 Jul;135(1):32-42. doi: 10.1016/j.jviromet.2006.01.018. Epub 2006 Mar 9. J Virol Methods. 2006. PMID: 16527364

6

Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.

Murata H, Macauley J, Lewis AM Jr, Peden K. Murata H, et al. Among authors: peden k. Vaccine. 2011 Apr 12;29(17):3155-61. doi: 10.1016/j.vaccine.2011.02.041. Epub 2011 Feb 26. Vaccine. 2011. PMID: 21354480

7

Application of quantitative methods for the detection of adventitious agents.

Peden K, Lewis AM Jr, Maudru T. Peden K, et al. Dev Biol (Basel). 2001;106:333-9. Dev Biol (Basel). 2001. PMID: 11761246 No abstract available.

8

A defined-risks approach to the regulatory assessment of the use of neoplastic cells as substrates for viral vaccine manufacture.

Lewis AM Jr, Krause P, Peden K. Lewis AM Jr, et al. Among authors: peden k. Dev Biol (Basel). 2001;106:513-35. Dev Biol (Basel). 2001. PMID: 11761266 No abstract available.

9

Recovery of strains of the polyomavirus SV40 from rhesus monkey kidney cells dating from the 1950s to the early 1960s.

Peden K, Sheng L, Omeir R, Yacobucci M, Klutch M, Laassri M, Chumakov K, Pal A, Murata H, Lewis AM Jr. Peden K, et al. Virology. 2008 Jan 5;370(1):63-76. doi: 10.1016/j.virol.2007.06.045. Epub 2007 Sep 27. Virology. 2008. PMID: 17900651 Free article.

10

Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice.

Manohar M, Orrison B, Peden K, Lewis AM Jr. Manohar M, et al. Among authors: peden k. Biologicals. 2008 Jan;36(1):65-72. doi: 10.1016/j.biologicals.2007.06.002. Epub 2007 Oct 22. Biologicals. 2008. PMID: 17933552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters